Endarterectomía iliofemoral en pacientes con diabetes

Referencias bibliográficas:

1. Wild S., Roglic G., Green A., Sicree R., and King H.: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: pp. 1047-1053
2. Criqui M.H., and Aboyans V.: Epidemiology of peripheral artery disease. Circ Res 2015; 116: pp. 1509-1526
3. Pasterkamp G.: Methods of accelerated atherosclerosis in diabetic patients. Heart 2013; 99: pp. 743-749
4. Rosei E.A., and Rizzoni D.: Small artery remodelling in diabetes. J Cell Mol Med 2010; 14: pp. 1030-1036
5. Ray A., Huisman M.V., and Tamsma J.T.: The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in type 2 diabetes mellitus. Eur J Intern Med 2009; 20: pp. 253-260
6. Naghavi M., Libby P., Falk E., Casscells W.S., Litovsky S., Rumberger J., et al: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 2003; 108: pp. 1772-1778
7. Fowkes F.G., Rudan D., Rudan I., Aboyans V., Denenberg J.O., McDermott M.M., et al: Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013; 382: pp. 1329-1340
8. Beckman J.A., Creager M.A., and Libby P.: Diabetes and atherosclerosis. JAMA 2002; 287: pp. 2570-2581
9. Thiruvoipati T., Kielhorn C.E., and Armstrong E.J.: Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes 2015; 6: pp. 961-969
10. Holden S.E., Barnett A.H., Peters J.R., Jenkins-Jones S., Poole C.D., Morgan C.L., et al: The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab 2013; 15: pp. 844-852
11. Faglia E.: Characteristics of peripheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds 2011; 10: pp. 152-166
12. Scholtes V.P., Peeters W., van Lammeren G.W., Howard D.P., de Vries J.P., de Borst G.J., et al: Type 2 diabetes is not associated with an altered plaque phenotype among patients undergoing carotid revascularization. A histological analysis of 1455 carotid plaques. Atherosclerosis 2014; 235: pp. 418-423
13. Van der Feen C., Neijens F.S., Kanters S.D., Mali W.P., Stolk R.P., and Banga J.D.: Angiographic distribution of lower extremity. Diabet Med 2002; 19: pp. 366-370
14. He C., Yang J., Li Y., Rong J., Du F., Yang Z., et al: Comparison of lower extremity atherosclerosis in diabetic and non-diabetic patients using multidetector computed tomography. BMC Cardiovasc Disord 2014; 14: pp. 125
15. Rocha-Singh K.J., Zeller T., and Jaff M.R.: Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv 2014; 83: pp. E212-E220
16. Niwamae N., Kumakura H., Kanai H., Araki Y., Kasama S., Sumino H., et al: Intravascular ultrasound analysis of correlation between plaque-morphology and risk factors in peripheral arterial disease. Ann Vasc Dis 2009; 2: pp. 27-33
17. Mueller T., Hinterreiter F., Luft C., Poelz W., Haltmayer M., and Dieplinger B.: Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg 2014; 59: pp. 1291-1299
18. Sprengers R.W., Janssen K.J., Moll F.L., Verhaar M.C., and van der Graaf Y.: Prediction rule for cardiovascular events and mortality in periphe